Table 3. Univariate and multivariate analysis of overall survival.
Variables | N | Univariate analysis |
Multivariate analysis |
||||
---|---|---|---|---|---|---|---|
Hazard ratio (95% CI) | HR P value | Hazard ratio (95% CI) | HR P value | ||||
Age at diagnosis | |||||||
≤65 | 30 | 1 | 1 | – | |||
>65 | 26 | 2.685 (1.052–6.853) | 0.039 | 3.67 (1.259–10.701) | 0.017 | ||
Size | |||||||
≤3 cm | 18 | 1 | – | 1 | – | ||
>3 cm | 17 | 0.381 (0.077–1.889) | 0.237 | 0.57 (0.132–2.467) | 0.452 | ||
Unknown | 21 | 1.392 (0.494–3.921) | 0.532 | 1.72 (0.592–4.994) | 0.319 | ||
Summary stage | |||||||
Localized | 18 | 1 | – | 1 | – | ||
Regional | 19 | 0.476 (0.119–1.903) | 0.294 | 0.688 (0.15–3.151) | 0.63 | ||
Distant | 8 | 0.877 (0.176–4.361) | 0.872 | 1.249 (0.224–6.971) | 0.8 | ||
Unknown | 11 | 1.818 (0.585–5.644) | 0.301 | 3.049 (0.897–10.359) | 0.074 | ||
Surgery of primary site | |||||||
No | 14 | 1 | – | – | |||
Yes | 42 | 0.642 (0.244–1.694) | 0.371 | 0.791 (0.237–2.64) | 0.703 | ||
Sex | |||||||
Male | 29 | 1 | – | – | |||
Female | 27 | 1.04 (0.421–2.565) | 0.933 | ||||
Region | |||||||
East | 20 | 1 | – | – | |||
Northern Plain | 3 | 0.548 (0.067–4.497) | 0.575 | ||||
Pacific Coast | 32 | 0.868 (0.341–2.208) | 0.766 | ||||
Southwest | 1 | – | – | ||||
Race | |||||||
White | 35 | 1 | – | – | |||
Other | 21 | 0.776 (0.324–1.86) | 0.569 | ||||
Primary site | |||||||
Main bronchus | 3 | 1 | – | – | |||
Upper lobe | 24 | 1.34 (0.166–10.79) | 0.783 | ||||
Middle lobe | 5 | 1.828 (0.188–17.77) | 0.603 | ||||
Lower lobe | 19 | 1.276 (0.157–10.3) | 0.819 | ||||
Overlapping lesion | 1 | – | – | ||||
Lung, NOS | 4 | 2.091 (0.187–23.47) | 0.55 | ||||
Radiation | |||||||
No | 43 | 1 | – | – | |||
Yes | 13 | 0.963 (0.375–2.475) | 0.938 |
CI, confidence interval.